News
AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from ...
Demand for basic necessities is relatively inelastic ... of an inferior good rises and demand goes up because consumers use more of it in place of costlier alternatives. Veblen goods are at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results